Improved Efficacy and Reduced Toxicity of Doxorubicin Encapsulated in Sulfatide-Containing Nanoliposome in a Glioma Model

• Jia Lin,

  Affiliations School of Medicine, Faculty of Health, Deakin University, Waurn Ponds, Victoria, Australia, Department of Biochemistry and Molecular Biology, West China School of Preclinical and Forensic Medicine, Sichuan University, Chengdu, P. R. China

  ⨯
• Sarah Shigdar,

  Affiliation School of Medicine, Faculty of Health, Deakin University, Waurn Ponds, Victoria, Australia

  ⨯
• Ding Zhi Fang,

  Affiliation Department of Biochemistry and Molecular Biology, West China School of Preclinical and Forensic Medicine, Sichuan University, Chengdu, P. R. China

  ⨯
• Dognxi Xiang,

  Affiliation School of Medicine, Faculty of Health, Deakin University, Waurn Ponds, Victoria, Australia

  ⨯
• Ming Q. Wei,

  Affiliation School of Medical Science and Griffith Health Institute, Griffith University, Gold Coast Campus, Southport, Australia

  ⨯
• Andrew Danks,

  Affiliation Department of Surgery, Southern Clinical School, Monash University, Clayton, Victoria, Australia

  ⨯
• Lingxue Kong,

  Affiliation Institute for Frontier Materials, Deakin University, Waurn Ponds, Victoria, Australia

  ⨯
• Lianghong Li,

  Affiliation Liaoning Key Laboratory of Cancer Stem Cell Research, Dalian Medical University, Dalian, China

  ⨯
• Liang Qiao,

  Affiliation Storr Liver Unit, Westmead Millennium Institute, the University of Sydney at the Westmead Hospital, Westmead, NSW, Australia

  ⨯
• Wei Duan

  * E-mail: wduan@deakin.edu.au

  Affiliation School of Medicine, Faculty of Health, Deakin University, Waurn Ponds, Victoria, Australia

  ⨯